Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H30O2 |
Molecular Weight | 290.4403 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])CC(=O)CC[C@]34C
InChI
InChIKey=NVKAWKQGWWIWPM-ABEVXSGRSA-N
InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
Molecular Formula | C19H30O2 |
Molecular Weight | 290.4403 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:00:47 UTC 2023
by
admin
on
Sat Dec 16 16:00:47 UTC 2023
|
Record UNII |
08J2K08A3Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2298
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
93995
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
1849-9
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
DEA NO. |
4000
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
747120
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
NCI_THESAURUS |
C243
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
43826-7
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Dihydrotestosterone
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
WHO-ATC |
G03BB02
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
15057-3
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
35189-0
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
6775-1
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
WHO-VATC |
QA14AA01
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
WHO-ATC |
A14AA01
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
LOINC |
1848-1
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
||
|
WHO-VATC |
QG03BB02
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID9022364
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
100000086923
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
521-18-6
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
C72098
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
3927
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL27769
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
16330
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
85278
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
m10190
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
208-307-3
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
DB02901
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
SUB05509MIG
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
10635
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
D013196
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
10972
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
238
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
08J2K08A3Y
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY | |||
|
DIHYDROTESTOSTERONE
Created by
admin on Sat Dec 16 16:00:48 UTC 2023 , Edited by admin on Sat Dec 16 16:00:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
DHT binds with greater affinity to SHBG than does testosterone
MAJOR
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|